University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

The Effect of Acute Minocycline Administration on Emotional Processing and Cognition in Healthy Volunteers

Not Applicable

Completed

Conditions: Cognitive Change
Mood

Interventions: Other: placebo
Drug: Minocycline

First Posted Date: 2018-12-07

Last Posted Date: 2019-04-18

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT03768557

Locations: 🇬🇧
Warneford Hospital, Oxford, Oxfordshire, United Kingdom

Losartan and Emotional Memory

Not Applicable

Completed

Conditions: Memory
Learning

Interventions: Other: placebo
Drug: Losartan Potassium

First Posted Date: 2018-12-04

Last Posted Date: 2018-12-06

Lead Sponsor: University of Oxford

Target Recruit Count: 53

Registration Number: NCT03763409

Locations: 🇬🇧
Department of Psychiatry, University of Oxford, Oxford, United Kingdom

Frozen Embryo Transfer With GnRH-antagonist Trial

Phase 4

Conditions: Infertility

Interventions: Drug: Cetrorelix Acetate

First Posted Date: 2018-12-04

Last Posted Date: 2019-04-25

Lead Sponsor: University of Oxford

Target Recruit Count: 300

Registration Number: NCT03763786

Locations: 🇬🇧
Oxford Fertility, Oxford, United Kingdom

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

Not Applicable

Recruiting

Conditions: Hypertension

Interventions: Diagnostic Test: Echocardiography scan

First Posted Date: 2018-12-03

Last Posted Date: 2018-12-03

Lead Sponsor: University of Oxford

Target Recruit Count: 750

Registration Number: NCT03762499

Locations: 🇬🇧
Cardiovascular Clinical Research Facility, Oxford, United Kingdom

Understanding RSV: Severe Disease and the Long Term Consequences

Active, not recruiting

Conditions: Respiratory Syncytial Virus (RSV)

Interventions: Diagnostic Test: RSV point of care testing

First Posted Date: 2018-11-28

Last Posted Date: 2022-11-22

Lead Sponsor: University of Oxford

Target Recruit Count: 315

Registration Number: NCT03756766

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, United Kingdom
🇬🇧
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Oxford, United Kingdom

IDEAL: Artificial Intelligence and Big Data for Early Lung Cancer Diagnosis Study

Completed

Conditions: Pulmonary Nodule, Solitary
Pulmonary Nodule, Multiple
Lung Cancer

First Posted Date: 2018-11-27

Last Posted Date: 2022-07-29

Lead Sponsor: University of Oxford

Target Recruit Count: 1293

Registration Number: NCT03753724

Locations: 🇬🇧
Nottingham University Hospitals Nhs Trust, Nottingham, Nottinghamshire, United Kingdom
🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom
🇬🇧
Royal Berkshire Nhs Foundation Trust, Reading, Berkshire, United Kingdom

and more 1 locations

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Phase 4

Recruiting

Conditions: Psoriatic Arthritis

Interventions: Drug: Methotrexate
Drug: Sulfasalazine
Drug: Adalimumab
Drug: Leflunomide

First Posted Date: 2018-11-14

Last Posted Date: 2023-11-29

Lead Sponsor: University of Oxford

Target Recruit Count: 315

Registration Number: NCT03739853

Locations: 🇬🇧
Oxford University Hospitals NHS Trust, Oxford, Oxfordshire, United Kingdom

LOSE-AF: Can Weight Loss Help Patients With Atrial Fibrillation?

Not Applicable

Recruiting

Conditions: Atrial Fibrillation
Overweight and Obesity

Interventions: Other: Meal Replacement Weight Loss Programme
Other: Usual Care

First Posted Date: 2018-10-22

Last Posted Date: 2023-12-15

Lead Sponsor: University of Oxford

Target Recruit Count: 180

Registration Number: NCT03713775

Locations: 🇬🇧
Oxford Centre for Magnetic Resonance (OCMR), Oxford, Oxfordshire, United Kingdom

An Efficacy Study of IV Boosting With ChAd63/MVA ME-TRAP

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: ChAd63 ME-TRAP and MVA ME-TRAP vaccination

First Posted Date: 2018-10-16

Last Posted Date: 2019-09-26

Lead Sponsor: University of Oxford

Target Recruit Count: 43

Registration Number: NCT03707353

Locations: 🇬🇧
NIHR Clinical Research Facility, Hammersmith Hospital, London, United Kingdom
🇬🇧
CCVTM, University of Oxford, Oxford, United Kingdom
🇬🇧
John Radcliffe Hospital, Oxford, United Kingdom

and more 1 locations

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease

Phase 3

Active, not recruiting

Conditions: Atherosclerotic Cardiovascular Disease

Interventions: Drug: Placebo
Drug: Inclisiran

First Posted Date: 2018-10-15

Last Posted Date: 2024-12-05

Lead Sponsor: University of Oxford

Target Recruit Count: 16124

Registration Number: NCT03705234

Locations: 🇬🇧
CTSU, University of Oxford, Oxford, Oxfordshire, United Kingdom
🇺🇸
TIMI Study Group, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy